The pharmacology of citalopram enantiomers: the antagonism by R-citalopram on the effect of S-citalopram.

Article Details

Citation
Copy to clipboard

Sanchez C

The pharmacology of citalopram enantiomers: the antagonism by R-citalopram on the effect of S-citalopram.

Basic Clin Pharmacol Toxicol. 2006 Aug;99(2):91-5. doi: 10.1111/j.1742-7843.2006.pto_295.x.

PubMed ID
16918708 [ View in PubMed
]
Abstract

Recent results on the in vivo and in vitro pharmacology of escitalopram are summarised. The exact molecular mechanism by which R-citalopram inhibits the effect of S-citalopram on the serotonin transporter remains to be elucidated. Preliminary evidence indicates an effect of R-citalopram on the association of escitalopram with the high affinity primary site, and on its dissociation from the serotonin transporter, via an allosteric mechanism. Escitalopram can be considered as an allosteric serotonin reuptake inhibitor. This serotonin dual action in binding to two sites on the serotonin transporter (both the primary site and the allosteric site) is hypothesised to be responsible for a longer binding to, and therefore greater inhibition of the serotonin transporter by escitalopram.

DrugBank Data that Cites this Article

Drugs